Immunic prices $65M underwritten offering of pre-funded warrants and Series A/B warrants

IMMUNIC, INC.

Offering of 86.7M pre-funded warrants plus Series A & B warrants at $0.7499 per unit; proceeds ~$65M.
Series A warrants ($0.75 exercise) expire Dec 31, 2025; Series B warrants ($0.75) exercisable from Oct 2025 or upon VWAP ≥$1.25.
Potential additional $130M gross proceeds if Series A and B warrants fully exercised for cash.
Leerink Partners sole bookrunner; B. Riley Securities and Brookline Capital co-managers; close expected June 3, 2025.
Proceeds to fund clinical trials and operations.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.